Case Study: a biopharmaceutical company achieves rapid, scalable GxP validation with Sware Res_Q

Helping a Precision Medicine Company Implement Rapid, Scalable GxP Validation

A biopharmaceutical company was facing a significant challenge managing its computer system validation (CSV) and GxP requirements for its growing number of SaaS applications, which required 25 to 30 validations per year. This burden was so great that it forced the reallocation of three full-time employees from their core mission-critical work, slowing down product development. This led the company to seek out a validation solution provider, ultimately selecting Sware and its Res_Q platform.

Sware implemented its cloud-native Res_Q solution to automate, unify, and accelerate the company's validation processes. This partnership saved the company approximately 102 FTE hours per validation project, freed internal teams to focus on high-priority tasks, and removed all paper-based processes. The solution provided a single platform to manage all validation, increasing visibility and ensuring ongoing audit-readiness. The Sware team also provided deep functional expertise, which the company found invaluable for answering complex compliance questions.